Sonim Technologies enters ATM equity offering agreement for up to $8.94M

DNA X, Inc.

Company entered Sales Agreement with Roth Capital Partners for ATM offering of common stock up to $8,943,000.
Shares sold at prevailing market prices; Agent receives 3.0% commission on gross proceeds.
Company not obligated to sell any shares; no assurance of any sales under the agreement.
Securities issued under effective shelf registration statement (File No. 333-278577).
Agreement includes indemnification; may be terminated by either party upon prior notice.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.